This week, Beyond Biotech examined the evolving landscape of neurodegenerative disease treatment through a conversation with Gain Therapeutics about their first-in-class approach to Parkinson's disease. The episode highlighted how novel mechanisms of action—in this case, protein misfolding correction rather than traditional dopamine replacement—are reshaping what's possible in diseases long considered difficult to modify.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (Jul 20 - Jul 26, 2026)
1 episode · Jul 20 – Jul 26
This Week in Beyond Biotech (Jul 13 - Jul 19, 2026)
1 episode · Jul 13 – Jul 19
This Week in Beyond Biotech (Jul 6 - Jul 12, 2026)
1 episode · Jul 6 – Jul 12
This Week in Beyond Biotech (Jun 29 - Jul 5, 2026)
1 episode · Jun 29 – Jul 5
This Week in Beyond Biotech (Jun 22 - Jun 28, 2026)
1 episode · Jun 22 – Jun 28
This Week in Beyond Biotech (Jun 15 - Jun 21, 2026)
1 episode · Jun 15 – Jun 21
This Week in Beyond Biotech (Jun 8 - Jun 14, 2026)
1 episode · Jun 8 – Jun 14
This Week in Beyond Biotech (Jun 1 - Jun 7, 2026)
1 episode · Jun 1 – Jun 7
This Week in Beyond Biotech (May 18 - May 24, 2026)
1 episode · May 18 – May 24
This Week in Beyond Biotech (May 11 - May 17, 2026)
1 episode · May 11 – May 17
This Week in Beyond Biotech (May 4 - May 10, 2026)
1 episode · May 4 – May 10
